Pfizer Quality Improvement Grants to improve the early suspicion, identification, and the management of patients with ATTR-CM
Well-being, Health and Biomedical Discovery
Deadlines
Academic Unit: inquire with unit
Memorial Deadline: Friday 24th, May 2024
External Deadline: Friday 31st, May 2024
Description
Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s GMG competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest, sets timelines for review and approval, and uses an expert review panel (ERP) to make final grant decisions. Organizations are invited to submit an application addressing the specific gaps in practice as outlined in the specific RFP.
For all independent quality improvement grants, the grant requester (and ultimately the grantee) is responsible for the design, implementation, and conduct of the independent initiative supported by the grant. Pfizer must not be involved in any aspect of project development, nor the conduct or monitoring of the quality improvement program.
Date RFP Issued: April 2, 2024
Geographic Scope: Canada
Clinical Area: Transthyretin Cardiac Amyloidosis (ATTR-CM)
Link to full RFP: Quality Improvement Grants to improve the early suspicion, identification, and the management of patients with ATTR-CM
Application Due Date: May 31, 2024
Specific Area of Interest: Pfizer is interested in receiving proposals that:
- – Improve the capabilities for disease suspicion and identification.
- – Reduce the time to correct diagnosis, among a broad audience of health care professionals, including increasing coordination across specialties.
- – Improve the patient’s holistic management.
– Adapt international best practices to Canadian context for improved patients’ outcomes. - Refer to complete details in the full RFP document. If you have questions regarding this RFP, please direct them in writing to Amanda Stein, Grant Officer (amanda.j.stein@pfizer.com).